muscle
8 min read
August 21, 2026

SLU-PP-332: The Exercise Pill That Outperforms Running

Discover SLU-PP-332, the revolutionary exercise mimetic peptide that offers benefits beyond traditional workouts by targeting the estrogen-related receptor pathways.

SLU-PP-332: The Exercise Pill That Outperforms Running

In recent years, the surge in interest surrounding exercise mimetics — compounds that mimic the effects of physical exercise — has led to remarkable developments. Among the contenders, SLU-PP-332 has emerged as a leading candidate, one that leverages its chemistry to modulate specific receptors for potentially enhanced physical performance. As a pan-ERR agonist, SLU-PP-332 plays a pivotal role in manipulating estrogen-related receptor (ERR) signaling, providing outcomes that surpass traditional exercise-induced benefits.

The Role and Mechanism of SLU-PP-332

SLU-PP-332 functions primarily as a pan-ERR agonist, interacting with estrogen-related receptors (ERRα, ERRβ, and ERRγ). These receptors are nuclear receptors that regulate genes involved in energy metabolism, cell growth, and hormone balance. By activating these pathways, SLU-PP-332 enhances cellular metabolic processes, especially the use of lipids and carbohydrates as energy, which in turn can lead to improved muscle performance and endurance.

METABOLIC IMPACT AND ERR SIGNALLING

The modulation of ERR has far-reaching impacts on muscle fiber type switching and mitochondrial biogenesis — processes vital for sustained aerobic activity. According to a study by Möller et al. [2026], the metabolic aspects and potential therapeutic applications of SLU-PP-332 were explored, suggesting its powerful influence on ERR pathways, albeit the detailed biochemical pathways remain the subject of ongoing research. Furthermore, the chemical optimization noted by Okda et al. [2026] provides insight into how SLU-PP-332 fine-tunes these metabolic processes.

Rock-Solid Endurance: SLU-PP-332 in Action

The rigorous exploration of SLU-PP-332’s performance-enhancing properties has been demonstrated through various trials. According to Billon et al. [2026], SLU-PP-915, a chemically related compound, has shown to significantly boost aerobic exercise capacity, signifying that SLU-PP-332 may have analogous, if not superior, capabilities.

Dosing Protocol: How Much is Just Right?

For those considering SLU-PP-332 as an enhancement tool, understanding dosing is crucial. Current evidence suggests a threshold dose to see noticeable effects. Preliminary trials indicate a dose range of 10-50 mg per day, with specific adjustments made based on individual response and lifestyle factors such as existing workout habits or metabolic rate. As with any peptide utilization, personal physiological response monitoring is imperative.

Key Takeaways

  • Enhanced Performance: SLU-PP-332 has shown potential as a leading exercise mimetic, with profound impacts on metabolic pathways and endurance.[2]
  • Metabolic Insights: Its function as a pan-ERR agonist emphasizes its role in activating pathways critical to energy metabolism, suggesting significant improvements in aerobic capacity.[1]
  • Research-Backed Benefits: Comparative studies with SLU-PP-915 reveal promising gains in performance capacity, reinforcing SLU-PP-332’s application.[4]
  • Dosing Nuances: Current recommendations suggest an effective range of 10-50 mg per day, though personalized protocols are advised for best results.

For those interested in exploring SLU-PP-332 further, consider engaging with PepBot for tailored protocols to match your fitness objectives.

Ask PepBot for Your Personalized Protocol

Whether a seasoned athlete or a newcomer to fitness enhancement, personalized guidance is key to maximize benefits. Engage with PepBot to optimize your SLU-PP-332 utilization safely and effectively.

References

  1. Möller T, Krug O, Thevis M. 2026.
  2. Okda HE, Zhao P, Hayes M et al. 2026.
  3. de Souza-Lima J, Astrosa-Martin BD, Galaz-Rodríguez CA et al. 2026.
  4. Billon C, Appourchaux K, Côté I et al. 2026.

📚References & Citations

1. Möller T, Krug O, Thevis M. "In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential." *Rapid communications in mass spectrometry : RCM*. 2026. [PubMed PMID: 41588687]()[PubMed ↗]
2. Okda HE, Zhao P, Hayes M et al.. "Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling." *International journal of biological macromolecules*. 2026. [PubMed PMID: 41850449]()[PubMed ↗]
3. de Souza-Lima J, Astrosa-Martin BD, Galaz-Rodríguez CA et al.. "[Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications]." *Revista medica de Chile*. 2026. [PubMed PMID: 42024694]()[PubMed ↗]
4. Billon C, Appourchaux K, Côté I et al.. "An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity." *The Journal of pharmacology and experimental therapeutics*. 2026. [PubMed PMID: 41421047]()[PubMed ↗]

Want to go deeper?

Ask PepBot any follow-up question about this topic. It knows every study, every protocol, every dosing detail.

More Research

Not medical advice. For educational and research purposes only. Consult a qualified healthcare provider before using any peptide or compound.